Interaction between glucose and lipid metabolism: More than diabetic dyslipidemia, Diabetes and Metabolism Journal (2015) Effects of semaglutide on cardiovascular risk factors and eating behaviors in Type 2 diabetes, Acta Diabetologica (2022) Semaglutide improves cardiometabolic risk factors in adults with overweight or obesity: STEP 1 and 4 exploratory analysis, Diabetes, Obesity, and Metabolism (2023) Semaglutide and cardiovascular outcomes in patient with Type 2 diabetes, New England Journal of Medicine (2016) The GLP-1 analogs liraglutide and semaglutide reduce atherosclerosis in ApoE-/- and LDLr-/- mice a mechanism that includes inflammatory pathways, JACC Basic to Translational Science (2018) Ozempic drug label, NIH DailyMed (2023) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
However, older adults are also more susceptible to B6-related peripheral neuropathy, and they may already have neuropathy from other causes such as diabetes or vascular disease
Weight loss : In astudyof 175 participants with overweight or obesity, those taking semaglutide lost 5.9% of their body weight at 3 months and 10.9% at 6 months
A minor inconvenience, not a catastrophe
This means you may need to discard remaining solution if your dose is very low and the vial outlasts its stability window
